| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000236869.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007606173 |
Resistant |
| ENSG00000236869.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.004549877 |
Resistant |
| ENSG00000236869.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.005790773 |
Sensitive |
